Previous close | 41.45 |
Open | 40.43 |
Bid | 41.17 x 200 |
Ask | 41.38 x 100 |
Day's range | 39.80 - 41.73 |
52-week range | 14.42 - 60.90 |
Volume | |
Avg. volume | 860,651 |
Market cap | 2.44B |
Beta (5Y monthly) | 1.76 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.82 |
Earnings date | 15 Nov 2024 - 19 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 52.79 |
It hasn't been the best quarter for Twist Bioscience Corporation ( NASDAQ:TWST ) shareholders, since the share price...
SOUTH SAN FRANCISCO, Calif., September 12, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the U.S. Green Building Council (USGBC) awarded the company’s Wilsonville, OR facility LEED certification, meeting sustainability standards for its building, operations and maintenance.
SOUTH SAN FRANCISCO, Calif., September 09, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its 2024 corporate responsibility report detailing Twist’s approach to sustainability, social responsibility and ethics. The report highlights Twist’s ongoing commitment to advancing sustainable initiatives to best serve customers, communities and the planet.